Article thumbnail

Specific Visualization of Glioma Cells in Living Low-Grade Tumor Tissue

By Sven R. Kantelhardt, Wouter Caarls, Anthony H. B. de Vries, Guy M. Hagen, Thomas M. Jovin, Walter Schulz-Schaeffer, Veit Rohde, Alf Giese and Donna J. Arndt-Jovin
Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2001). A dual path programmable array microscope (PAM): simultaneous acquisition of conjugate and non-conjugate images.
  2. (2007). A new solution route to hydrogen-terminated silicon nanoparticles: synthesis, functionalization and water stability.
  3. (2007). Amplification of the epidermal growth factor receptor gene in glioblastoma: An analysis of the relationship between genotype and phenotype by CISH method.
  4. (2008). An Integrated Genomic Analysis of Human Glioblastoma Multiforme. Science.
  5. (1988). Biological and karyotypic characterization of a new cell line derived from human gliosarcoma.
  6. (1990). Bulfone A
  7. (2006). Changing paradigms–an update on the multidisciplinary management of malignant glioma.
  8. (2008). Comprehensive genomic characterization defines human glioblastoma genes and core pathways.
  9. (2006). Diffusely infiltrative low-grade gliomas in adults.
  10. (2006). Engineering luminescent quantum dots for In vivo molecular and cellular imaging.
  11. (2006). Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2: 494–503; quiz 491 p following 516.
  12. (2006). Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas.
  13. (2006). Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours.
  14. (2009). Expression of Integrin a 6b1enhances tumorigenesis in glioma cells.
  15. (2008). Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas.
  16. (2006). Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.
  17. (2007). Gene dosage and mutational analyses of EGFR in oligodendrogliomas.
  18. (2008). Giese A
  19. (2008). Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma.
  20. (2009). Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations.
  21. (2001). Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis.
  22. (2004). Imaging takes a quantum leap.
  23. (2006). In vivo cell imaging with semiconductor quantum dots and noblemetal nanodots.
  24. (2007). Incidence of the main genetic markers in glioblastoma multiforme is independent of tumor topology.
  25. (2007). Ligandconjugated quantum dots monitor antigen uptake and processing by dendritic cells.
  26. (2007). Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma.
  27. (2007). Quantitative single particle tracking of NGF-receptor complexes: transport is bidirectional but biased by longer retrograde run lengths.
  28. (2004). Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction.
  29. (2005). Quantum dots for live cells, in vivo imaging, and diagnostics.
  30. (2005). Reaching out for signals: filopodia sense EGF and respond by directed retrograde transport of activated receptors.
  31. (2008). Stem cell marker CD133 affects clinical outcome in glioma patients.
  32. (2010). Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival.
  33. (2007). The
  34. (1997). The autocrine loop of TGF-alpha/EGFR and brain tumors.
  35. (2007). The epidermal growth factor receptor in malignant gliomas: pathogenesis and therapeutic implications.
  36. (2009). Tumor-targeted quantum dots can help surgeons find tumor boundaries.